Literature DB >> 9174896

Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina.

C D Agardh1, E Agardh, H Zhang, C G Ostenson.   

Abstract

The Goto-Kakizaki (GK) rat represents a model of hereditary non-insulin-dependent diabetes mellitus (NIDDM), characterized by nonobesity, mild hyperglycemia from early life, impaired glucose tolerance test results, and a markedly defective insulin response to glucose. The rats develop signs of both nephropathy and neuropathy, but, to our knowledge, retinal changes have not been reported so far in this model of NIDDM. Hence, the aim of the present study was to assess whether morphological vascular changes could be demonstrated in retinal vessel preparations of GK rats. The endothelial/pericyte ratio was found to be higher in GK rats aged 8 months as well as after 24-30 months compared to their matched controls (2.3 +/- 0.2 versus 2.0 +/- 0.1; p < 0.01, and 2.6 +/- 0.2 versus 1.9 +/- 0.1; p < 0.001, respectively). Furthermore, in 24 to 30-months-old GK rats, the endothelial/pericyte ratio was higher than in 8 month old GK rats (p < 0.05). Thus, the GK rat appears to be a suitable model for experimental studies of chronic complications, including diabetic retinopathy, in NIDDM.

Entities:  

Mesh:

Year:  1997        PMID: 9174896     DOI: 10.1016/s1056-8727(96)00049-9

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  11 in total

Review 1.  Nonproliferative and Proliferative Lesions of the Ratand Mouse Special Sense Organs(Ocular [eye and glands], Olfactory and Otic).

Authors:  Meg Ferrell Ramos; Julia Baker; Elke-Astrid Atzpodien; Ute Bach; Jacqueline Brassard; James Cartwright; Cynthia Farman; Cindy Fishman; Matt Jacobsen; Ursula Junker-Walker; Frieke Kuper; Maria Cecilia Rey Moreno; Susanne Rittinghausen; Ken Schafer; Kohji Tanaka; Leandro Teixeira; Katsuhiko Yoshizawa; Hui Zhang
Journal:  J Toxicol Pathol       Date:  2018-07-28       Impact factor: 1.628

2.  Carl-David Agardh, 1946-2013.

Authors:  Leif Groop; Åke Lernmark; Jan Nilsson
Journal:  Diabetologia       Date:  2014-04       Impact factor: 10.122

Review 3.  Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.

Authors:  Hiroshi Kitamura
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

4.  JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.

Authors:  T Ohta; N Furukawa; G Komuro; F Yonemori; K Wakitani
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 5.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

6.  Reduced innervation and delayed re-innervation after epithelial wounding in type 2 diabetic Goto-Kakizaki rats.

Authors:  Feng Wang; Nan Gao; Jia Yin; Fu-Shin X Yu
Journal:  Am J Pathol       Date:  2012-10-10       Impact factor: 4.307

Review 7.  Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.

Authors:  Harshini Chakravarthy; Vasudharani Devanathan
Journal:  J Mol Neurosci       Date:  2018-10-06       Impact factor: 3.444

Review 8.  Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.

Authors:  Remya Robinson; Veluchamy A Barathi; Shyam S Chaurasia; Tien Y Wong; Timothy S Kern
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

Review 9.  Animal Models of Diabetic Retinopathy.

Authors:  Ana Maria Olivares; Kristen Althoff; Gloria Fanghua Chen; Siqi Wu; Margaux A Morrisson; Margaret M DeAngelis; Neena Haider
Journal:  Curr Diab Rep       Date:  2017-08-24       Impact factor: 4.810

10.  An Aqueous Extract of Radix Astragali, Angelica sinensis, and Panax notoginseng Is Effective in Preventing Diabetic Retinopathy.

Authors:  Dehong Gao; Yijuan Guo; Xuejun Li; Xiumin Li; Zhipeng Li; Mei Xue; Zhimin Ou; Ming Liu; Mingxing Yang; Suhuan Liu; Shuyu Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.